Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Ery-Ped (Erythromycin Ethylsuccinate) Oral Suspention & E.E.S. Granules Oral Suspension
Company:  Abbott Laboratories
Application No.:  050207S054 & 050207S055
Approval Date: 2/04/2000


Date created: October 212004

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.